FDA
approval
· 2025-11-24
FDA Approved: OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE — Original Application (Micro Labs Limited)
Summary
The FDA approved a fixed-dose combination tablet containing olmesartan medoxomil, amlodipine besilate, and hydrochlorothiazide under Micro Labs Limited’s origin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE)